Nuveen’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9M Buy
402,357
+15,255
+4% +$1.19M 0.01% 891
2025
Q4
$30.6M Sell
387,102
-7,973
-2% -$690K 0.01% 899
2025
Q3
$36.2M Buy
395,075
+24,099
+6% +$1.97M 0.01% 788
2025
Q2
$24.2M Buy
370,976
+322,375
+663% +$21M 0.01% 975
2025
Q1
$3.25M Sell
48,601
-1,042
-2% -$62.2K ﹤0.01% 2135
2024
Q4
$2.74M Sell
49,643
-132,385
-73% -$7.6M ﹤0.01% 2251
2024
Q3
$10.9M Sell
182,028
-137,114
-43% -$8.36M ﹤0.01% 1551
2024
Q2
$20.3M Buy
319,142
+72,986
+30% +$4.74M 0.01% 1122
2024
Q1
$17M Buy
246,156
+86,862
+55% +$5.24M 0.01% 1274
2023
Q4
$8.78M Sell
159,294
-62,137
-28% -$3.42M ﹤0.01% 1672
2023
Q3
$12.9M Buy
221,431
+180,491
+441% +$10.4M ﹤0.01% 1325
2023
Q2
$2.2M Hold
40,940
﹤0.01% 2301
2023
Q1
$1.63M Sell
40,940
-3,977
-9% -$168K ﹤0.01% 2423
2022
Q4
$1.81M Sell
44,917
-6,115
-12% -$230K ﹤0.01% 2433
2022
Q3
$1.64M Sell
51,032
-602
-1% -$20.6K ﹤0.01% 2501
2022
Q2
$1.53M Buy
51,634
+12,560
+32% +$362K ﹤0.01% 2578
2022
Q1
$1.05M Buy
39,074
+3,427
+10% +$128K ﹤0.01% 2803
2021
Q4
$1.6M Sell
35,647
-3,167
-8% -$136K ﹤0.01% 2675
2021
Q3
$1.12M Sell
38,814
-2,200
-5% -$68.4K ﹤0.01% 2955
2021
Q2
$1.44M Sell
41,014
-5,176
-11% -$176K ﹤0.01% 2859
2021
Q1
$1.67M Buy
46,190
+3,922
+9% +$123K ﹤0.01% 2698
2020
Q4
$1.23M Buy
42,268
+3,841
+10% +$110K ﹤0.01% 2732
2020
Q3
$1.08M Buy
38,427
+137
+0.4% +$4.08K ﹤0.01% 2650
2020
Q2
$1.24M Sell
38,290
-20,556
-35% -$737K ﹤0.01% 2527
2020
Q1
$2.4M Sell
58,846
-3,017
-5% -$160K ﹤0.01% 2102
2019
Q4
$3.81M Sell
61,863
-5,056
-8% -$335K ﹤0.01% 2128
2019
Q3
$4.88M Sell
66,919
-19,100
-22% -$1.43M ﹤0.01% 1967
2019
Q2
$7.07M Buy
+86,019
New +$6.12M ﹤0.01% 1802

Other funds holding ANIP